ProCE Banner Activity

How I Manage Immunotherapy-Related Adverse Events in My Patients Receiving Blinatumomab

Clinical Thought
I discuss a patient with ALL who received immunotherapy and how we managed the associated adverse events.

Released: November 17, 2015

Expiration: November 15, 2016

No longer available for credit.

Share

Faculty

Elias Jabbour

Elias Jabbour, MD

Assistant Professor
Department of Leukemia
University of Texas M. D. Anderson Cancer Center
Houston, Texas

Provided by

Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC
ProCE Banner

Supporters

This activity is supported by an educational donation from

Amgen, Inc.

Faculty Disclosure

Primary Author

Elias Jabbour, MD

Assistant Professor
Department of Leukemia
University of Texas M. D. Anderson Cancer Center
Houston, Texas

Elias Jabbour, MD, has disclosed that he has received consulting fees from Amgen, Ariad, Pfizer, and Teva.